Mr Robert Narquizian

KANDO id: 1031236

Bio

Being part of the Inkef team since February 2018, Robert has more than 20 years of experience in the Pharmaceutical and Biotech Industry. Medicinal Chemist by formation, with over 100 patents and co-authored peer reviewed scientific papers, Robert has led a number of projects from initial concept all the way to phase 2 clinical trials / proof of concept studies. He has contributed to a large number of pharma-related transactions as Director of Business Development and Licensing at Roche, as Head of Asia Pacific Global External R&D at Lilly based in Shanghai and more recently through his own consulting firm. Not only is Robert experienced within the global pharma market, he also has a great interest in the ever-developing Asia pharma market. Robert graduated with a PhD in Chemistry from The University of Glasgow, Scotland; he completed his post-doc at Harvard University and holds an Executive MBA from the London Business School.

Career


INKEF Capital

Joint venture of OMERS and ABP
From

Education